Skin cancer is the most common cancer in the U.S., affecting millions worldwide. This cancer comes in two main types: melanoma, which is less common but more deadly, and nonmelanoma skin cancers, which include basal cell carcinoma and squamous cell carcinoma.  Dr. Collin Costello, a Mayo Clinic dermatologist, says these nonmelanoma skin cancers are more prevalent – and with early diagnosis and treatment, the prognosis is good. Watch: The Mayo Clinic Minute https://www.youtube.com/watch?v=d57yn6wPCDs Journalists: Broadcast-quality video (1:00) is in the d ..read more

Amanda Eilian, of New York, visited her doctor in 2010 after her child called the mole on her wrist a 'chocolate' stain. While a doctor initially dismissed it, the spot turned out to be melanoma. (Source: the Mail online | Health ..read more

(MedPage Today) -- CHICAGO -- Preoperative intralesional treatment with a dual antibody-cytokine fusion significantly improved relapse-free survival (RFS) in locally advanced melanoma versus surgery alone, a randomized trial showed. Median RFS... (Source: MedPage Today Dermatology ..read more

Moderna says the same mRNA technology that fueled its COVID-19 vaccine is proving effective in fighting melanoma. The company presented the latest results from its trial involving 157 people with advanced skin cancer at the annual meeting of the American Society of Clinical Oncology in Chicago. In the study, Moderna and Merck combined their cancer treatments—Moderna’s experimental cancer vaccine and Merck’s approved checkpoint inhibitor pembrolizumab (Keytruda)—to achieve potentially life-changing results for melanoma patients. [time-brightcove not-tgx=”true”] In the phase 2 study of patients ..read more

The new vaccine approach will help improve survival rates for ‘the next decades and more’, says Cancer Research UK’s chief clinicianThe world ’s first personalised mRNA cancer vaccine for melanoma halves the risk of patients dying or the disease returning, according to trial results that doctors described as “extremely impressive”.Melanoma affects more than 150,000 people a year globally, according to 2020 figures from World Cancer Research Fund International.Continue reading... (Source: Guardian Unlimited Science ..read more

Skin cancer is the most common cancer in the U.S., and it only takes one blistering sunburn during childhood or adolescence to nearly double a person's chance of developing melanoma later in life, according to the American Academy of Dermatology Association. Since babies are much more prone to sunburn than older kids, it's especially important to protect them from the sun's harmful ultraviolet (UV) rays. May is Melanoma and Skin Cancer Awareness Month. In this… (Source: News from Mayo Clinic ..read more

Rates of melanoma skin cancer have risen in the U.K. by almost one-third over the last ten years, a charity has warned. (Source: Forbes.com Healthcare News ..read more

Melanoma, while rare, is one of the most dangerous types of skin cancer accounting for four out of five deaths from the disease. Charities warn a record 20,000 Brits could get this cancer this year. (Source: the Mail online | Health ..read more

South Korea-based Lunit plans to highlight scientific findings related to its Lunit Scope Suite for precision oncology at the upcoming American Society of Clinical Oncology (ASCO) 2024 annual meeting in Chicago.The studies include comprehensive histopathomic prediction models for early breast cancer and hypothetical test-and-control group generation for treatment selection in non-small cell lung cancer (NSCLC). In the area of breast cancer, Lunit will present findings of recent HER2 studies, including ultra-low expression in breast cancer using AI-based quantification, and subcellular qua ..read more

Cancer Research UK notes particular rise in diagnoses among older people and says majority of cases are preventableRates of melanoma skin cancer have reached an all-time high in the UK, according to analysis that highlights a substantial rise in the number of cases over the past decade, particularly among older people.New diagnoses increased by almost a third from 21 to 28 in every 100,000 people between 2007-09 and 2017-19, according to Cancer Research UK (CRUK) figures, with a 57% rise among the over-80s and a 7% rise in those aged 25 to 49.Continue reading... (Source: Guardian Unlimited Sci ..read more